by nobilistx | May 2, 2020 | Uncategorized |
PORTLAND, Ore., May 2, 2020 – Nobilis Therapeutics announced today the issuance of a Notice of Allowance (European Patent Application No: 16815312.0) for a patent titled “Therapeutic immune modulation using noble gas compositions.” “We have uncovered substantial...